Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.25Price to Book
VS
Market
Sector
Industry
History
$ 2.02Close
$ 0.25 - $ 3.64 52-Week Range
Ticker Information
Ticker
RLMDCompany Name
RELMADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRELMADA THERAPEUTICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RLMD - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 15.95M | $ 19.98M | 1.25 |
| 3/31/2025 | $ 22.44M | $ 13.21M | 0.59 |
| 12/31/2024 | $ 35.52M | $ 9.89M | 0.28 |
| 9/30/2024 | $ 47.63M | $ 98.37M | 2.07 |
| 6/30/2024 | $ 61.49M | $ 97.76M | 1.59 |
| 3/31/2024 | $ 72.05M | $ 115.57M | 1.6 |
| 12/31/2023 | $ 85.36M | $ 162.04M | 1.9 |
| 9/30/2023 | $ 100.73M | $ 90.3M | 0.9 |
| 6/30/2023 | $ 111.34M | $ 76.45M | 0.69 |
| 3/31/2023 | $ 125.47M | $ 95.41M | 0.76 |
Key Performance Insights, Last 5 Years
- RELMADA THERAPEUTICS INC's latest trailing twelve months (TTM) P/B stands at 4.37.
- Over the past 5 years, RELMADA THERAPEUTICS INC's average P/B has been 2.48.
- The median P/B for RELMADA THERAPEUTICS INC during this period was 1.75
- RELMADA THERAPEUTICS INC reached its highest P/B over the past 5 years at 6.19.
- The lowest P/B recorded by RELMADA THERAPEUTICS INC in the same timeframe 0.28
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for RELMADA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 533.53M ] / Equity [ $ 122.21M ]
(=) P/B [ 4.37 ] RLMD - Price to Book, Last 5 years
0.28
Minimum
Dec 31, 2024
6.19
Maximum
Mar 31, 2021
2.48
Average
1.75
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |